TickerKhojComparison · NSE · data 2026-11-03
Amrutanjan Health Care Limited vs Lyka Labs Limited
In plain words
Size: Amrutanjan Health Care Limited is about 5.2 times the market value of Lyka Labs Limited.
Return on equity: Amrutanjan Health Care Limited 16.6% vs Lyka Labs Limited -10.2%.
Debt to equity: Lyka Labs Limited 0.53 vs Amrutanjan Health Care Limited 0.
Differences in the numbers, not a recommendation of either stock.
Side by side
| AMRUTANJAN | LYKALABS | |
|---|---|---|
| Price | ₹496.4 | ₹75.07 |
| Market cap | ₹1,452 cr | ₹278 cr |
| P/E | 26.6 | — |
| P/B | — | 2.8 |
| ROE | 16.6% | -10.2% |
| ROCE | 17.9% | -9.9% |
| Debt / equity | 0 | 0.53 |
| Operating margin | 11.6% | -3.4% |
| Dividend yield | 0.99% | 0.00% |
| Sales growth, 3 years (yearly) | 9.8% | 11.8% |
| Profit growth, 3 years (yearly) | 13.3% | — |
| 1-year return | -31.3% | -23.6% |
| Revenue, last 12 months | ₹511 cr | ₹145 cr |
| Net profit, last 12 months | ₹54 cr | ₹-4 cr |
| Latest quarter | Jun 2026 | Sept 2026 |
| Quarter net profit | ₹4 cr | ₹1 cr |
| Quarter profit vs a year earlier | -47.4% | — |
| Promoter holding | 46.52% | 58.45% |
| Health check | Average (5.7/10) | Weak (2.3/10) |
Common questions
Which earns a higher return on equity?
Amrutanjan Health Care Limited (16.6% against -10.2%).
Which carries more debt?
Lyka Labs Limited has the higher debt-to-equity ratio (0.53 against 0).